Results 241 to 250 of about 265,822 (283)

Preclinical Retinal Disease Models: Applications in Drug Development and Translational Research. [PDF]

Pharmaceuticals (Basel)
Soundara Pandi SP, Winter H, Smith MR, Harkin K, Bojdo J.   +4 more
europepmc   +1 more source

Nanotherapy for Neural Retinal Regeneration

Advanced Science, EarlyView.
Nanotechnology enhances ophthalmic treatments by improving drug delivery and regenerating ocular tissues, combating vision loss from retinal diseases through innovative nano‐systems. This review outlines ocular anatomy, pathology, immune microenvironment, and barriers, detailing nanocarrier characteristics, classification, and preparation methods, and ...
Chuyao Yu, Li Dong, Yujia Lv, Xuhan Shi, Ruiheng Zhang, Wenda Zhou, Haotian Wu, Heyan Li, Yitong Li, Zhou Li, Dan Luo, Wen‐Bin Wei   +11 more
wiley   +1 more source

Predicting Pharmacokinetics in Rats Using Machine Learning: A Comparative Study Between Empirical, Compartmental, and PBPK-Based Approaches. [PDF]

Clin Transl Sci
Walter M, Aljayyoussi G, Gerner B, Rapp H, Tautermann CS, Balazki P, Skalic M, Borghardt JM, Humbeck L.   +8 more
europepmc   +1 more source

European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection. [PDF]

Neuro Oncol
Sahm F, Bertero L, Brandner S, Capper D, Goldbrunner R, Jenkinson MD, Kalamarides M, Lamszus K, Albert NL, Mair MJ, Berghoff AS, Mawrin C, Wirsching HG, Maas SLN, Raleigh DR, Reifenberger G, Schweizer L, Suwala AK, Tabatabai G, Tabouret E, Short S, Wen PY, Weller M, Le Rhun E, Wesseling P, van den Bent M, Preusser M.   +26 more
europepmc   +1 more source

m276-SL-PBD eradicates tumors and instigates long-lasting tumor-free survival in Merkel cell carcinoma preclinical models. [PDF]

iScience
Kunika MD, Kannan A, Velasco GJ, Feng Y, Seaman S, Das BK, Pham D, Lambrecht N, Zhao H, St Croix B, Gao L.   +10 more
europepmc   +1 more source

Considerations for mRNA Product Development, Regulation and Deployment Across the Lifecycle. [PDF]

Vaccines (Basel)
Skerritt JH.
europepmc   +1 more source

Cancer-on-a-chip for precision cancer medicine.

Lab Chip
Liu L, Wang H, Chen R, Song Y, Wei W, Baek D, Gillin M, Kurabayashi K, Chen W.   +8 more
europepmc   +1 more source

A drug combination therapy consisting of toxin phospholipase A2 and metalloproteinase inhibitors provides preclinical protection against North AmericanCrotalidsnakebite envenoming

Dawson CA, Marriott AE, Crittenden E, Westhorpe A, Stars E, Edge RJ, Hall SR, Menzies SK, Clare RH, Casewell NR.   +9 more
europepmc   +1 more source